Are playing a game of tennis and believe that the holders of debt won, now with each passing day I think that ALAN is the one that takes advantage and the rest starts to get nervous. Stop us the best is that this continues and there could be surprise.
With CFDA should know how long it takes to approve it if it works at level II which is where they want to be class II to manufacture it. Because if it works in 100 days they could approve it to the misfortune of the holders of debt.
Flaviker, it's easy to make bold statements when it's not your money that would have to be invested by MTIA to get cfda approval. The mard number you quoted at 12 is 25% more then the other CGM'S on the market. That is a huge difference to overcome in addition to the inconcistentcy readings. MTIA knows more then anyone if the CGM can be commercialized or had ascertained an outside opinions from experts in medical devises if the technology they currently have will be sufficient to develop a non invasive CGM.
MTIA never made a firm committment to Echo to fund them. Have you seen any such a document.
News 
Market Data 
Discover 
AI
